LATEST DEVELOPMENTS
● In November 2021, Japan’s Amgen, Bushu Pharma expanded supply chain partnership across Japan and Asia Pacific.
● In September 2021, The President of Taiwan proposed to implement space technology to advance industrial development in biotech and medical supply chain.
● In August 2021, Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions and Mitsubishi Logistics Corporation, Japan’s leading pharma logistics company, announced a multi-year strategic business alliance to create an integrated regenerative medicine supply chain partnership in Japan.
● In August 2021, EMA endorsed recommendations developed by the International Coalition of Medicines Regulatory Authorities (ICMRA) to facilitate the use of track and trace systems at the global level.